Lenzetto

Estradiol, the active ingredient in Lenzetto, is an estrogen presented as a transdermal patch for transdermal use. It is prescribed to alleviate menopausal symptoms such as hot flashes and vaginal atrophy, and to treat estrogen deficiency states in women.

GNH USA supplies Lenzetto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Clients benefit from reliable logistics, competitive pricing, and dedicated technical support throughout the supply chain.

Lenzetto, an estrogen replacement therapy, is used to manage conditions associated with low estrogen levels.

- Menopausal symptoms: reduces frequency and severity of hot flashes, night sweats, and improves vaginal atrophy. - Estrogen deficiency states: restores physiological estrogen concentrations in hypoestrogenic women. - Bone health maintenance: helps preserve bone mineral density and reduces risk of osteoporosis in postmenopausal patients.

Lenzetto may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Skin irritation at the patch site: redness, itching, or rash. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Breast tenderness: swelling or discomfort.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Severe allergic reaction: anaphylaxis or angioedema.

Before prescribing Lenzetto, clinicians should consider several safety measures.

- Cardiovascular assessment: evaluate history of thromboembolism or stroke before initiating therapy. - Breast monitoring: perform regular clinical exams and imaging as indicated. - Liver function: monitor hepatic enzymes in patients with liver disease. - Pregnancy avoidance: do not use in women who are pregnant or may become pregnant. - Concomitant hormone therapy: avoid combining with other estrogen products without specialist advice. - Store at room temperature: keep the patch in its original pouch, protect from moisture and direct heat.

Lenzetto can interact with other medicines, requiring attention to the nature of the interaction.

Major Interactions (Avoid): - Combined estrogen with anticoagulants (e.g., warfarin): increased risk of bleeding. - Estrogen plus hormonal contraceptives: heightened thromboembolic risk. - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): markedly reduced estradiol exposure.

Moderate Interactions (Monitor Closely): - SSRIs such as paroxetine or fluoxetine: may alter estradiol metabolism. - Lithium therapy: estradiol may increase lithium serum levels. - Antihypertensive agents: estrogen can affect blood pressure control.